Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel
product pipeline of neurology therapies to address high unmet medical needs, with a focus on epilepsy. For more
information, please visit www.xenon-pharma.com.